Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer (Q39790634)
Jump to navigation
Jump to search
scientific article published on 6 October 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer |
scientific article published on 6 October 2009 |
Statements
1 reference
Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer (English)
1 reference
Irene Zinonos
1 reference
Agatha Labrinidis
1 reference
Michelle Lee
1 reference
Vasilios Liapis
1 reference
Shelley Hay
1 reference
Vladimir Ponomarev
1 reference
Peter Diamond
1 reference
Andrew C W Zannettino
1 reference
David M Findlay
1 reference
Andreas Evdokiou
1 reference
6 October 2009
1 reference
1 reference
8
1 reference
10
1 reference
2969-2980
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference